Proteins as a 'shuttle service' for targeted administration of medication

Prof. Dr. Yves Muller and Karin Schmidt Image: FAU/Johannes Schweininger

Using medication in a targeted manner and getting it to its point of action without damaging healthy tissue on the way is a key issue at the moment in pharmaceutical research. Staff at the FAU’s Chair of Biotechnology led by Prof. Dr. Yves Muller and lead author of the study Karin Schmidt have developed a new solution for this process. In collaboration with researchers from Friedrich-Schiller Universität Jena, they were able to demonstrate that a certain group of proteins can be restructured to form tissue-specific ‘shuttles’ for medication.

Methodological basis

A computer-aided process developed by the Chair of Biotechnology and experiments in the laboratory were required in order to solve the difficult task of designing proteins in such a manner so as to allow substances (so-called legates) to be bound to them. The researchers used crystallography in particular for this purpose.

In a game of ‘ping pong’ between applications on the computer and the laboratory, the researchers successfully converted a protein of human origin called antichymotrypsin into proteins to which they could bind a well-known antibiotic (Doxycyclin) and a widely-used cytostatic drug (Doxorubicin) that is used for treating cancer and autoimmune diseases.

The bound medication is then released in the target tissue by splitting the shuttle protein with a so-called proteinase enzyme. The published study now provides experimental proof of the fact that the medication was bound to the proteins and how it was achieved and lays the foundation for more detailed investigation.

Potential future areas of application

Using the protein shuttles could enable medication to be used in lower doses in a targeted manner without major procedures and with fewer side effects. This would lower the impact of the medication on the rest of the body and other organs and enable the active ingredients in the drugs to be used more effectively.

‘We have a long and difficult path ahead of us before certain proteins can be used as shuttles in medical applications,’ says Prof. Dr. Yves Muller, who led the study. The first step is to further increase the binding affinity of the drugs to the shuttle proteins. ‘The key has to fit even more precisely into the keyhole,’ says Prof. Dr. Muller. The Chair of Biotechnology at FAU will be intensely involved with this project during the next few years.

The next step involves extending the project to clinical applied research. Experimental proof must then demonstrate that the mechanisms also work in tissue. However, the researchers are hopeful that their model study has the potential for developing directed shuttles for medication and could be groundbreaking for targeted and efficient administration of medication.

*The results of the research were published with the title ‘Design of an allosterically modulated doxycycline and doxorubicin drug-binding protein’ in the journal ‘Proceedings of the National Academy of Sciences’ (PNAS) https://doi.org/10.1073/pnas.1716666115.

Further information:
Karin Schmidt
Phone: +49 9131 8523073
karin.schmidt@fau.de

Prof. Dr. Yves Muller
Phone: +49 9131 8523082
yves.muller@fau.de

Media Contact

Dr. Susanne Langer idw - Informationsdienst Wissenschaft

All latest news from the category: Life Sciences and Chemistry

Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.

Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.

Back to home

Comments (0)

Write a comment

Newest articles

New yttrium-hydrogen compounds discovered

Researchers at the University of Bayreuth have made a significant scientific breakthrough by discovering new yttrium-hydrogen compounds having serious implications for the research on high-pressure superconductivity. High-pressure superconductivity refers to…

New AI model detects ninety percent of lymphatic cancer cases

Medical image analysis using AI has developed rapidly in recent years. Now, one of the largest studies to date has been carried out using AI-assisted image analysis of lymphoma, cancer…

UTA preps giant particle detectors for neutrino project

Excavation of caverns part of Fermilab’s Deep Underground Neutrino Experiment. With excavation work complete at the site where four gigantic particle detectors for the international Deep Underground Neutrino Experiment (DUNE) will be…

Partners & Sponsors